Indian Navy Dexamethasone Sodium Phosphate and Pharmaceutical Supply Procurement

Work Description - NA

This tender presents a critical procurement opportunity for the Department of Military Affairs, operating under the Ministry of Defence, specifically for the Indian Navy. The bid, identified by GEM/2026/B/7834750 and dated 17-08-2026, closes on 07-09-2026 at 5:00 PM. The core requirement revolves around the supply of a substantial quantity, totaling 4647 units, of "Dexamethasone Sodium Phosphate 4 point 4 mg Equivalent". This vital medication is further detailed within the Bill of Quantities (BOQ) to include specific formulations such as Dexamethasone Phosphate 4 mg per 2 ml Injection, Ciprofloxacin HCl 0.3% plus Dexamethasone 0.1% bottle of 5 ml, Frusemide 20 mg 2 ml Injection, Clotrimazole 1% w/v IP plus Lignocaine 2% IP eardrop bottle of 10 ml, and Calcium 9 mg plus Calcium Gluconate 50mg Injection for IV use 10 ml. This comprehensive tender underscores the Indian Navy's need for essential pharmaceutical supplies to ensure the health and operational readiness of its personnel.